TipVision Videoscope System (TipVision VideoScope 0°/30°; EleVision HD 2 Camera Control Unit (CCU))

K201617 · Schoelly Fiberoptic GmbH · HET · Mar 12, 2021 · Obstetrics/Gynecology

Device Facts

• Record ID: K201617
• Device Name: TipVision Videoscope System (TipVision VideoScope 0°/30°; EleVision HD 2 Camera Control Unit (CCU))
• Applicant: Schoelly Fiberoptic GmbH
• Product Code: HET · Obstetrics/Gynecology
• Decision Date: Mar 12, 2021
• Decision: SESE
• Submission Type: Traditional
• Regulation: 21 CFR 884.1720
• Device Class: Class 2

Intended Use

The TipVision™ 0°/30° Videoscopes and EleVision™ HD 2 CCU are indicated for visualization during general laparoscopy, gynecological laparoscopy, urological laparoscopy, and video-assisted minimally invasive thoracic procedures.

Device Story

TipVision Videoscope System comprises a rigid 0°/30° videoscope and EleVision HD 2 Camera Control Unit (CCU). Device captures anatomical images via a distal-tip CMOS sensor and integrated LED illumination; transmits data via cable to CCU for processing. CCU outputs full HD (1080p) video to a compatible monitor. Used in hospitals, clinics, and medical offices by physicians for endoscopic surgery. User controls imaging parameters (magnification, brightness, color enhancement) via scope handle buttons or CCU interface. System provides real-time visualization to assist surgeons in diagnostic and therapeutic procedures, potentially improving surgical precision and patient outcomes through enhanced endoscopic imaging.

Clinical Evidence

Bench testing only. No clinical data provided. Testing included reprocessing validation (cleaning/sterilization), biocompatibility (ISO 10993), optical performance (ISO 8600 series), photobiological safety (IEC 62471), electrical safety (IEC 60601-1), and EMC (IEC 60601-1-2).

Technological Characteristics

Rigid videoscope with distal CMOS sensor and integrated LED illumination. Full HD (1080p) resolution. 0°/30° view. 10mm diameter. Reusable; steam sterilizable. Wired connection to CCU. Software-controlled image processing (magnification, color enhancement). Complies with IEC 60601-1, IEC 60601-2-18, and IEC 60601-1-2.

Indications for Use

Indicated for visualization during general, gynecological, and urological laparoscopy, and video-assisted minimally invasive thoracic procedures in patients requiring endoscopic surgery.

Regulatory Classification

Identification

A gynecologic laparoscope is a device used to permit direct viewing of the organs within the peritoneum by a telescopic system introduced through the abdominal wall. It is used to perform diagnostic and surgical procedures on the female genital organs. This generic type of device may include: Trocar and cannula, instruments used through an operating channel, scope preheater, light source and cables, and component parts.

Predicate Devices

• EndoEYE HD II Videoscope (K111788)
• Visera Elite Video System Center (OTV-S190) (K111425)

Submission Summary (Full Text)

{0}------------------------------------------------

Image /page/0/Picture/0 description: The image shows the logo of the U.S. Food and Drug Administration (FDA). On the left is the Department of Health & Human Services logo. To the right of that is the FDA logo, which is a blue square with the letters "FDA" in white. To the right of the blue square is the text "U.S. FOOD & DRUG ADMINISTRATION" in blue.

March 12, 2021

Schoelly Fiberoptic GmbH % Pamela Papineau, RAC Regulatory Affairs Consultant (Alternate Application Contact) Delphi Medical Device Consulting, Inc. 5 Whitcomb Avenue Ayer, MA 01432

Re: K201617

> Trade/Device Name: TipVision Videoscope System (TipVision VideoScope 09/30°; EleVision HD 2 Camera Control Unit (CCU)) Regulation Number: 21 CFR§ 884.1720 Regulation Name: Gynecologic Laparoscope and Accessories Regulatory Class: II Product Code: HET, GCJ, FET Dated: February 4, 2021 Received: February 5, 2021

Dear Pamela Papineau:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

{1}------------------------------------------------

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies.

You must comply with all the Act's requirements. including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatoryinformation/postmarketing-safety-reporting-combination-products); good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.

For comprehensive regulatory information about medical devices and radiation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email ([e-mail]) or phone [phone] or 301-796-7100).

Sincerely,

For

Jason R. Roberts, Ph.D. Assistant Director DHT3B: Division of Reproductive, Gynecology and Urology Devices OHT3: Office of GastroRenal, ObGyn, General Hospital and Urology Devices Office of Product Evaluation and Quality Center for Devices and Radiological Health

Enclosure

{2}------------------------------------------------

#### Indications for Use

510(k) Number (if known) K201617

Device Name

TipVision Videoscope System (TipVision VideoScope 0°/30°; EleVision HD 2 Camera Control Unit (CCU))

Indications for Use (Describe)

The TipVision 0%30° Videoscopes and EleVision HD 2 CCU are indicated for visualization during general laparoscopy, gynecological laparoscopy, urological laparoscopy, and video-assisted minimally invasive thoracic procedures.

| Type of Use (Select one or both, as applicable) |
|-------------------------------------------------|
|-------------------------------------------------|

X Prescription Use (Part 21 CFR 801 Subpart D)

| Over-The-Counter Use (21 CFR 801 Subpart C)

#### CONTINUE ON A SEPARATE PAGE IF NEEDED.

This section applies only to requirements of the Paperwork Reduction Act of 1995.

#### *DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.*

The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:

> Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff [e-mail]

"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."

{3}------------------------------------------------

#### 510(k) Summary

### A. GENERAL INFORMATION

| 510(k) Sponsor: | Schoelly Fiberoptic GmbH |
|--------------------------|--------------------------------------------------------|
| Address: | Robert-Bosch-Str. 1 – 3<br>79211 Denzlingen<br>Germany |
| FDA Registration Number: | 8043903 |
| Telephone Number: | [phone] |
| Fax Number: | [phone] |
| Contact Person: | Dr. Sandra Baumann |
| Date Prepared: | 11 March 2021 |

#### B. DEVICE IDENTIFICATION:

| Trade/Device Name: | TipVision™ Videoscope System (TipVision Videoscope 0°/30°;<br>EleVision HD 2 Camera Control Unit (CCU)) | | |
|--------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--|--|
| Regulation Name: | Gynecologic Laparoscope And Accessories | | |
| Regulation Number: | 21 CFR 884.1720 (Gynecologic Laparoscope and Accessories) | | |
| Product Code: | HET (laparoscope, gynecologic (and accessories))<br>GCJ (laparoscope, general & plastic surgery)<br>FET (endoscopic video imaging system/component,<br>gastroenterology-urology) | | |
| Regulatory Class: | Class II | | |

# C. PREDICATE DEVICES:

Predicate 1 - Videoscope

| Trade Name: | EndoEYE HD II Videoscope; |
|-----------------|---------------------------|
| 510(k) Sponsor: | Olympus America, Inc. |
| 510(k) Number: | K111788 |

Recall: The Endoeye HD II Video Telescope cleared in predicate K111788 was the subject of a class II design related recall due to a damaged temperature sensor in the distal end of the endoscope. The issue has been successfully resolved and design changes have been cleared via K190744. The installed heating element warms the distal tip to minimize or eliminate fogging of the lens during the procedure and aids in the prevention of endoscope removal to clean the lens due to fogging during a procedure. The TipVision Videoscope System does not include this feature.

{4}------------------------------------------------

| Predicate 2 – Camera Control Unit | |
|-----------------------------------|---------------------------------------------|
| Trade Name: | Visera Elite Video System Center (OTV-S190) |
| Sponsor: | Olympus Medical Systems Corp. |
| 510(k) Number: | K111425 |

There were no design-related recalls associated with this device.

# D. DEVICE DESCRIPTION:

The Tip Vision™ Videoscope System, consisting of the Tip Vision 0° / 30° Videoscope and the EleVision™ HD 2 Camera Control Unit (CCU), is used for 2D visualization of anatomical structures of the human body during endoscopic surgery including general laparoscopy, gynecological laparoscopy, urological laparoscopy, and video-assisted minimally invasive thoracic surgical procedures. The TipVision™ Videoscope can only be used with the EleVision™ HD 2 CCU; this combination of videoscope and camera controller results in a camera based on complementary metal-oxide-semiconductor (CMOS) technology with LED illumination. When used with a compatible monitor, the camera delivers a native full HD image resolution using progressive scanning (1080p). All parameters that can be adjusted through the user interface of the CCU (magnification, illumination brightness, saturation, selective color enhancement, color shift, image storage, etc.) can also be controlled by the buttons on the TipVision™ Videoscope.

The Tip Vision™ Videoscope is connected to the Ele Vision™ HD 2 CCU by means of a cable attached to the scope handpiece. The user has the ability to adjust videoscope imaging parameters using the buttons on the videoscope handle, or via the CCU. The EleVision™ HD 2 CCU is available in two configurations: image recording only, or image and video recording.

#### INDICATIONS FOR USE: E.

The TipVision™ 09/30° Videoscopes and EleVision™ HD 2 CCU are indicated for visualization during general laparoscopy, gynecological laparoscopy, urological laparoscopy, and video-assisted minimally invasive thoracic procedures.

#### COMPARISON OF SUBJECT DEVICE TECHNILOGICAL F. CHARACTERISTICS WITH THE PREDICATE DEVICES

A comparison of the technicological characteristics was conducted between the subject device and two predicate devices, one for the videoscope (Olympus EndoEYE HD II videoscope cleared under K111788) and one for the CCU (Olympus Visera Elite Video System Center cleared under K111425). A detailed comparison of the subject and predicate devices is provided in the table below.

{5}------------------------------------------------

#### Technological Characteristics Comparison Table - Videoscope

| Attribute | Proposed<br>TipVision 0° / 30°<br>Videoscope<br>(current submission) | Predicate Device<br>Olympus EndoEYE HD II<br>(K111788) | Similarities and Differences |
|---------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications for Use | The TipVision™ 0°/30°<br>Videoscopes and<br>EleVision™ HD 2 CCU<br>are indicated for<br>visualization during general<br>laparoscopy, gynecological<br>laparoscopy, urological<br>laparoscopy, and video-<br>assisted minimally invasive<br>thoracic surgical<br>procedures. | This instrument has been<br>designed to be used with a<br>video system center, light<br>source, documentation<br>equipment, monitor, hand<br>instruments, electrosurgical<br>instrument, and other<br>ancillary equipment for<br>endoscope and endoscopic<br>surgery within the thoracic<br>and abdominal cavities<br>including the female<br>reproduction organs | Different indications for use;<br>Same intended use:<br>visualization during general<br>laparoscopic / endoscopic,<br>gynecological, urological,<br>and thoracic surgical<br>procedures |
| Use Environment | Hospital, clinic, medical<br>office | Hospital, clinic, medical<br>office | Same |
| System Components | TipVision™ Videoscope<br>(rigid video endoscope) | Olympus Endoeye HD 2<br>Videoscope (rigid video<br>endoscope) | Same |
| Principle of<br>Operation | Rigid videoscope with<br>imaging chip in distal tip;<br>wired connection between<br>videoscope and CCU | Rigid videoscope with<br>imaging chip in distal tip;<br>wired connection between<br>videoscope and CCU | Same |
| Light Source | Integrated LEDs in<br>endoscope tip, powered by<br>CCU | External light source<br>connected to the endoscope,<br>light transmission through<br>endoscope via fiber optics | Different technology; same<br>performance |
| Image<br>Transmission | CMOS chip in scope tip | CCD chip in scope tip | Different technology:<br>same performance |
| Direction of View | 0°, 30° | 0°, 30° | Same |
| Field of View | 76° | 72°, 80°, 90° | Similar; within predicate range |
| Tip Rotation | 170° | N/A | Different |
| Depth of Field | 20 mm – 200 mm | 20 mm – 200 mm | Same |
| Image Resolution | Full HD (1080) | Full HD (1080) | Same |
| Insertion Tube<br>Working Length | 341 mm | 300 mm – 330 mm | Similar |
| Insertion Tube<br>Outer Diameter | 10 mm | 5.4 mm, 10 mm | Same; within predicate range |
| Scope Internal<br>Channels | None | None | Same |
| Scope Power Source | Wired connection<br>between videoscope and<br>CCU | Wired connection<br>between videoscope and<br>CCU | Same |
| Control Buttons on<br>Scope Handpiece | Yes, user-configurable | Yes, user-configurable | Same |
| Biocompatibility | Yes | Yes | Same |
| Single Use /<br>Reusable | Reusable | Reusable | Same |
| Scope Reprocessing | Cleaning (manual or<br>automated) and steam<br>sterilization | Cleaning (manual or<br>automated), steam<br>sterilization | Same |
| Scope Moisture<br>Resistance | IPX 7 | IPX 7 | Same |
| Electrical Safety &<br>Thermal Safety | Yes | Yes | Same |
| Electromagnetic<br>Compatibility | Yes | Yes | Same |
| Scope Safety<br>Performance | Yes | Yes | Same |

{6}------------------------------------------------

# Technological Characteristics Comparison

| | Proposed<br>TipVision™ Videoscope<br>System<br>(current submission) | Predicate Device<br>Olympus Visera Elite<br>Video System Center and<br>Light Source (K111425) | Similarities and Differences |
|---------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications for Use | The TipVision™ 0°/30°<br>Videoscopes and<br>EleVision™ HD 2 CCU<br>are indicated for<br>visualization during general<br>laparoscopy, gynecological<br>laparoscopy, urological<br>laparoscopy, and video-<br>assisted minimally invasive<br>thoracic surgical<br>procedures. | Visera elite video system<br>center: this video system<br>center has been designed to<br>be used with olympus<br>camera heads, endoscopes,<br>light sources, monitors,<br>endo-therapy accessories<br>and other ancillary<br>equipment for endoscopic<br>diagnosis, treatment and<br>video observation. | Different indications for use;<br>Same intended use:<br>visualization during general<br>laparoscopic / endoscopic,<br>gynecological, urological, and<br>thoracic surgical procedures |
| | | Visera elite xenon light<br>source: this light source has<br>been designed to be used<br>with olympus endoscopes,<br>video system center, and<br>other ancillary equipment<br>for endoscopic diagnosis. | |

{7}------------------------------------------------

| | | treatment and video observation. | |
|------------------------------------|-------------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------|------|
| Use Environment | Hospital, clinic, medical office | Hospital, clinic, medical office | Same |
| Principle of Operation | CCU provides power to videoscope and performs video image processing; image can be viewed on a compatible video monitor | CCU provides power to videoscope and performs video image processing; image can be viewed on a compatible video monitor | Same |
| Single Use / Reusable | Reusable | Reusable | Same |
| Software | Yes | Yes | Same |
| Electrical Safety & Thermal Safety | Yes | Yes | Same |
| EMC | Yes | Yes | Same |

Differences in technological characteristics do not raise different questions of safety and effectiveness.

# A. SUMMARY OF NON-CLINICAL PERFORMANCE TESTING:

#### Reprocessing:

Reprocessing validations weredesigned and conducted in accordance with FDA's 2015 guidance (including Appendix E revised June 2017) Reprocessing Medical Devices in Health Care Settings: Validation Methods and Labeling.

Cleaning studies were designed and performed in accordance with AAMI TIR12:2010 Designing, Testing and Labeling Reusable Medical Devices for Reprocessing in Health Care Facilities: A Guide for Device Manufacturers, AAMI TIR30:2011(R)2016 A compendium of processes, materials, test methods, and acceptance criteria for cleaning reusable devices.

Sterilization studies were designed and performed in accordance with AAMI TIR12:2010 Designing, Testing and Labeling Reusable Medical Devices for Reprocessing in Health Care Facilities: A Guide for Device Manufacturers, and ANSVAAMI/ISO 17665-1:2006 (R)2013 Sterilization of health care products – Moist heat – Part 1: Requirements for the development, validation and routine control of a sterilization process for medical devices. Cleaning and sterilization processes are defined in the device labeling per ISO 17664:2017 Processing of health care products - Information to be provided by the medical device manufacturer for the processing of medical devices.

These tests demonstrated that the device successfully passed cleaning, drying and sterilization validations according to the instructions in the user manual.

#### Biocompatibility:

The patient contacting component of the subject device system is the videoscope insertible. The contact category for this component is Tissue/Bone/Dentin Communicating, ≤24 hours.

{8}------------------------------------------------

The videoscope insertion tube was evaluated and tested for biocompatibility in accordance with the following standards and the FDA guidance document "Use of International Standard ISO 10993-1. "Biological evaluation of medical devices - Part 1: Evaluation and testing within a risk management process":

- ISO 10993-1:2018 Biological evaluation of medical devices Part 1: Evaluation . and testing within a risk management process
- ISO 10993-5:2009 Biological evaluation of medical devices Part 5: Tests for in ● vitro cytotoxicity
- . ISO 10993-10:2010 Biological evaluation of medical devices – Part 10: Tests for irritation and skin sensitization
- . ISO 10993-11:2017 Biological evaluation of medical devices – Part 11: Tests for systemic toxicity
- . 42-NF37:2019 USP <151> Pyrogen Test (USP Rabbit Test)

#### Performance Testing:

Optical performance (direction of view, field of view, distortion/resolution, luminous flux, color performance, photobiological safety), optical safety, and thermal safety testing were conducted in accordance with the standards listed below:

- . ISO 8600-1:2015 Medical endoscopes and endotherapy devices – Part 1: General requirements
- ISO 8600-3:2019 Medical endoscopes and endotherapy devices Part 3: . Determination of Field of View and Direction of View of Endoscopes with Optics
- . ISO 8600-5:2005 Optics and photonics – Medical endoscopes and endotherapy devices - Part 5: Determination of Optical Resolution of Rigid Endoscopes with Optics
- IEC 62471:2006 (First Edition) Photobiological safety of lamps and lamp systems
- IEC 60601-2-18:2009 Medical electrical equipment, Part 2-18: Particular ● requirements for the basic safety and essential performance of endoscopic equipment

The following additional testing was performed by the sponsor in support of device performance:

- Usability testing per IEC 60601-1-6:2016 .
- Noise and Dynamic Range testing ●
- Mechanical testing for the tip rotation ●

#### Software Documentation:

Software documentation for a Moderate Level of Concern device is provided in support of the subject device per FDA's 2005 Guidance for the Content of Premarket Submissions for Software Contained in Medical Device. The software lifecycle, including software documentation and validation, is managed in accordance with IEC 62304:2006/A1:2016 Medical Device Software - Software Life Cycle Processes.

{9}------------------------------------------------

#### Electrical Safety Testing:

The TipVision™ Videoscope System was assessed for conformity with, and was found to comply with, the relevant requirements of IEC 60601-1:2005 + CORR. 1:2006 + CORR. 2:2007 + AM1:2012 (ed. 3.1, including the US deviations) Medical electrical equipment, Part 1: General requirements for basic safety and essential performance.

The TipVision™ Videoscope System was assessed for conformity with, and was found to comply with, the relevant requirements of IEC 60601-2-18:2009 (3rd edition): Particular requirements for the basic safety and essential performance of endoscopic equipment.

#### Electromagnetic Compatibility Testing:

The TipVision™ Videoscope System was assessed for conformity with, and was found to comply with, the relevant requirements of IEC 60601-1-2 (4th Edition) Medical electrical equipment, Part 1-2: General requirements for safety – Collateral standard: Electromagnetic Compatibility - Requirements and tests.

# B. CONCLUSION

The performance testing summarized above support a substantial equivalence determination. The performance testing demonstrate that the subject device is as safe and as effective as the legally marketed predicate devices.